These Analysts Boost Their Forecasts On Hims & Hers After Upbeat Earnings
Portfolio Pulse from Avi Kapoor
Hims & Hers Health, Inc. (NYSE:HIMS) reported better-than-expected Q4 earnings, beating analyst estimates with earnings of 1 cent per share and quarterly sales of $246.62 million. The company also issued strong guidance for Q1 2024 and FY 2024, expecting to surpass $1 billion in revenue. Following the report, HIMS shares surged 31.9% to $13.52. Analysts from Truist Securities, Piper Sandler, Citigroup, and Guggenheim have subsequently raised their price targets on HIMS.
February 27, 2024 | 6:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Hims & Hers Health, Inc. reported strong Q4 earnings and optimistic guidance for 2024, leading to a significant share price increase and raised price targets by analysts.
The positive earnings report and strong future revenue guidance directly impact HIMS's stock by increasing investor confidence and attracting positive analyst attention, which in turn can lead to a higher stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100